Seoul Pharma

018680 · KOSDAQ · ₩018680 · 서울제약

₩1,884▼ ₩15 (0.79%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩52B₩54B₩52B₩50B₩40B
Cost of sales₩21B₩21B₩21B₩18B₩15B
Gross profit₩32B₩33B₩32B₩32B₩25B
Operating income−₩1.3B₩1.5B₩1.2B₩1.7B−₩5.7B
Net income₩754M₩1.7B₩3.5B₩855M−₩9.7B
Net income to shareholders₩754M₩1.7B₩3.5B₩855M−₩9.7B

Balance sheet

20252024202320222021
Total assets₩72B₩72B₩63B₩62B₩62B
Current assets₩34B₩32B₩26B₩26B₩25B
Cash and equivalents₩9.9B₩7.5B₩6.6B₩12B₩14B
Total liabilities₩31B₩31B₩25B₩27B₩43B
Current liabilities₩15B₩14B₩21B₩14B₩29B
Borrowings₩10B₩10B₩10B₩14B₩28B
Total equity₩41B₩40B₩39B₩35B₩19B
Shareholders' equity₩41B₩40B₩39B₩35B₩19B

Cash flow

20252024202320222021
Cash from operations₩1.9B−₩3B₩5.3B−₩78M−₩1.7B
Capital spending₩861M₩2.2B₩1.9B₩1.2B₩1.2B
Free cash flow₩1B−₩5.2B₩3.4B−₩1.3B−₩2.8B
Dividends paid———₩0₩0

Consolidated where available. Amounts in won.

Also known as: Seoul Pharma / 서울제약 / 018680 / KRX:018680

Source: KRX statistical information